original ) (raw )Cytomegalovirus Infection in Kidney Transplant Recipients
Lada Zibar
2021
View PDFchevron_right
Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients
Jolanta Gozdowska
BMC Infectious Diseases, 2018
View PDFchevron_right
Cytomegalovirus Infection after Renal Transplantation: Occurrence, Clinical Features, and the Cutoff for Antigenemia in a University Hospital in Brazil
Roberto Meyer
Infection & chemotherapy, 2017
View PDFchevron_right
Diagnostic Usefulness of Cytomegalovirus (CMV)-Specific T Cell Immunity in Predicting CMV Infection after Kidney Transplantation: A Pilot Proof-of-Concept Study
Young-hoon Kim
Infection & chemotherapy, 2015
View PDFchevron_right
Cytomegalovirus infection in renal transplant patients
Petar Kes
2008
View PDFchevron_right
Use of Laboratory Assays To Predict Cytomegalovirus Disease in Renal Transplant Recipients
Luis Cuevas
Journal of Clinical Microbiology, 1998
View PDFchevron_right
Association of the Outcome of Renal Transplantation with Antibody Response to Cytomegalovirus Strain--Specific Glycoprotein H Epitopes
T. Suzutani
Clinical Infectious Diseases, 2007
View PDFchevron_right
Predictive factors for cytomegalovirus reactivation in cytomegalovirus-seropositive kidney-transplant patients
Laure Esposito
Journal of Medical Virology, 2008
View PDFchevron_right
Seroprevalence of Cytomegalovirus Antibody in Renal Transplant Recipients and Donors in Khuzestan Province, Iran
Ali Ghorbani
2010
View PDFchevron_right
Comparison of antigenemia (pp65) assay and polymerase chain reaction in diagnosis of cytomegalovirus infection in renal transplant recipients treated with atg
Magdalena Durlik
Transplantation Proceedings, 2000
View PDFchevron_right
Antigenemia for Cytomegalovirus in Renal Transplantation: Choosing a Cutoff For the Diagnosis Criteria in Cytomegalovirus Disease
Jorge Neumann
Transplantation Proceedings, 2005
View PDFchevron_right
Cytomegalovirus infection in renal transplant recipients is associated with impaired survival irrespective of expected mortality risk
Anders Hartmann
Clinical transplantation, 2007
View PDFchevron_right
Prevalence and Clinical Impact of Cytomegalovirus Infection and Disease in Renal Transplantation: Ten Years of Experience in a Single Center
N. Ouzounidis
Transplantation Proceedings, 2012
View PDFchevron_right
Cellular Immunity to Predict the Risk of Cytomegalovirus Infection in Kidney Transplantation: A Prospective, Interventional, Multicenter Clinical Trial
Anna Manonelles
Clinical Infectious Diseases, 2020
View PDFchevron_right
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients
Michael Derby
Antimicrobial agents and chemotherapy, 2016
View PDFchevron_right
Monitoring of human cytomegalovirus infection by antigenemia assay in seropositive renal transplant recipients
Gözde ERSOY
International Journal of Infectious Diseases, 2002
View PDFchevron_right
The impact of early cytomegalovirus infection after kidney transplantation on long-term graft and patient survival
Aksel Foss
Clinical Transplantation, 2014
View PDFchevron_right
UP1.152: Cytomegalovirus Infection and Disease Following Renal Transplantation: Preliminary Report of Incidence and Potential Risk Factors
Hamed Ahmadi
Urology, 2009
View PDFchevron_right
The impact of early cytomegalovirus infection and disease in renal transplant recipients
Anders Hartmann
Clinical Microbiology and Infection, 2005
View PDFchevron_right
Cytomegalovirus Infection and Disease Following Renal Transplantation: Preliminary Report of Incidence and Potential Risk Factors
Ebrahim Kalantar
Transplantation Proceedings, 2009
View PDFchevron_right
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression: CMV and immunosuppressive regimens
Stanislas Bataille
Transplant Infectious Disease, 2010
View PDFchevron_right
Cytomegalovirus risk factors in renal transplantation with modern immunosuppression
Stanislas Bataille
2010
View PDFchevron_right
Cytomegalovirus DNA concentration in plasma predicts development of cytomegalovirus disease in kidney transplant recipients
Ellen Holter , M. Degré
Clinical Microbiology and Infection, 2002
View PDFchevron_right
Human Cytomegalovirus and Kidney Transplantation: A Clinician's Update
Steven Van Laecke
American Journal of Kidney Diseases, 2011
View PDFchevron_right
Early cytomegalovirus‐specific T‐cell response and estimated glomerular filtration rate identify patients at high risk of infection after renal transplantation
Antonella La Russa
Transplant Infectious Disease, 2016
View PDFchevron_right
Live Cytomegalovirus Vaccination of Renal Transplant Candidates
John Glazer
Annals of Internal Medicine, 1979
View PDFchevron_right
Comparing cytomegalovirus prophylaxis in renal transplantation: single center experience
László Kóbori , E. Sarvary
Transplant Infectious Disease, 2005
View PDFchevron_right
Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients
Masayoshi Okumi
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2017
View PDFchevron_right